Holen Sie sich die Stockscreener-App
0.873
0.92%
0.008
Handel nachbörslich:
.96
0.087
+9.97%
180 Life Sciences Corp Aktie (ATNF) Neueste Nachrichten
180 Life Sciences Adopts 2025 Option Incentive Plan - TipRanks
Stocks to Watch: Jio Financial Services, Hero MotoCorp, Zydus Lifesciences, Abbott and more - CNBC TV18
Wealthcare Advisory Partners LLC Makes New Investment in Abrdn Life Sciences Investors (NYSE:HQL) - Defense World
Weiss Ratings Reiterates “Sell (E+)” Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
908 Devices’ (MASS) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Equities Analysts Set Expectations for TLSI FY2026 Earnings - Defense World
Layoff Tracker: Capsida Downsizes as Part of Shift to Clinical-Stage Company - BioSpace
Anavex Life Sciences Corp. (NASDAQ:AVXL) Stock Holdings Lessened by BNP Paribas Financial Markets - Defense World
4D Molecular Therapeutics (NASDAQ:FDMT) Receives Sell (E+) Rating from Weiss Ratings - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by BNP Paribas Financial Markets - Defense World
180 Life Sciences’ (ATNF) Sell (E+) Rating Reaffirmed at Weiss Ratings - Defense World
Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan
Tower Research Capital LLC TRC Buys 1,708 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Brings Alzheimer's and Parkinson's Drug Updates to Prestigious Wainwright Healthcare Conferences - Stock Titan
180 Life Sciences’ (ATNF) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World
Edwards Lifesciences CEO and CFO Set for Exclusive Fireside Chat at Major BofA Healthcare Conference - Stock Titan
180 Life Sciences Announces That the University of Oxford Has Been Awarded a Grant From the National Institute for Health and Care Research in the U.K. to Conduct a Clinical Trial in Post Operative Delirium/Cognitive Deficit in a Jointly Funded Program - Barchart.com
ATNF’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Breakthrough Diabetes Treatment: New Neuromodulation Device Eliminates Need for Insulin Injections - Stock Titan
180 Life Sciences Gets Notice of Allowance for Method to Prevent POCD - marketscreener.com
MAGIC Nashville Showcases Premier Southeastern Women's Fashion Trends and Innovations - Digital Journal
180 Life Sciences (ATNF) Secures Patent Approval for POCD Treatm - GuruFocus
180 Life Sciences nears patent for post-surgery cognitive aid By Investing.com - Investing.com India
180 Life Sciences nears patent for post-surgery cognitive aid - Investing.com
180 Life Sciences Corp. Announces Notice of Allowance for U.S. P - GuruFocus
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction | ATNF Stock News - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
Patent Breakthrough: 180 Life Sciences Develops First Treatment to Prevent Post-Surgery Cognitive Decline in Elderly - Stock Titan
Budapest Draws in Summer Visitors for an Adventure Along the Danube - Digital Journal
180 Life Sciences (ATNF) Restructures Capital with Share Repurch - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure By Investing.com - Investing.com India
180 Life Sciences Settles Disputes with Elray Resources - TipRanks
180 Life Sciences Corp. Announces Share Repurchase | ATNF Stock News - GuruFocus
180 Life Sciences to buy back shares, simplifies capital structure - Investing.com Australia
180 Life Sciences Launches Massive 23% Share Reduction Plan: Key Details of $1M Strategic Buyback - Stock Titan
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Increase in Short Interest - Defense World
Short Interest in Adlai Nortye Ltd. (NASDAQ:ANL) Decreases By 51.6% - Defense World
Q4 Results This Week: BPCL, Varun Beverages, Vedanta, SBI, Trent Among 180+ Companies To Declare Earnings - NDTV Profit
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules - ACCESS Newswire
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
Dupuytren's Disease Market Valuation Expected To Reach $8.54 Billion By 2029 Growing At A Rate Of 9% As Rev... - WhaTech
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Geode Capital Management LLC Sells 247,336 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - Yahoo Finance
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter
ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):